Center for Cell and Gene Therapy

Disclosure of Outside Interests for CAGT Investigators

Master
Content

The following are current disclosure of outside interests for the Center for Cell and Gene Therapy investigators.

Content

Helen Heslop, M.D.

Interest Company
Equity

Allovir
Marker Therapeutics
Fresh Wind Biotechnologies
CoRegen Inc.

Scientific Advisory Board

Gilead Biosciences
Novartis
Tessa Therapeutics
Marker Therapeutics
Kiadis
PACT Pharma
Mesoblast
Ankyra Therapeutics

Research Support Tessa Therapeutics
Kuur Therapeutics
Royalties None
Spouse Disclosures None
Other None

 

Content

Malcolm Brenner, M.D., Ph.D.

Interest Company
Equity Allovir
Marker Therapeutics
Tessa Therapeutics
Scientific Advisory Board

Tessa Therapeutics
Marker Therapeutics
Allogene
Walking Fish
Kuur
Turnstone Biologics
Posedia
Tscan
Bluebird Bio
Adaptimmune Therapeutics
Adintus
Onkimure
Triumvira Immunologics
Allogene
Bellicum Pharmaceuticals
Memgen, LLC
Brooklyn Immunotherapeutics
Coya
Astrazeneca Pharmaceuticals

Research Support None
Royalties Takeda
Bellicum
Maker Therapeutics
Spouse Disclosures See Cliona Rooney
Stock Turnstone, Bluebird Bio, Allogene, Walking Fish, AlloVir, Tessa, Tscan
Leadership Founder Member Maker Therapeutics 
Consulting Memgen, Bellicum, KURR, Tessa, Turnstone, Bluebird Bio, Allogene, Walking Fish, Abintus Bio and Adaptimmune  
Other None

 

Content

Bambi Grilley

Interest Company
Equity AlloVir, QBRegulatory LLC
Scientific Advisory Board  
Research Support  
Royalties None
Spouse Disclosures None
Other

QBRegulatory Consulting, LLC provides or has provided consulting services to AlloVir, Marker Therapeutics, Tessa Therapeutics, Lokon Pharma, March Bio and Proxima Clinical Research

 

Content

Natalia Lapteva

Interest Company
Equity None
Scientific Advisory Board None
Research Support Tessa Therapeutics
Royalties None
Spouse Disclosures None
Other Consultant for Tessa Therapeutics

 

Content

Carlos Ramos 

Interest Company
Equity None
Scientific Advisory Board Novartis
Research Support Tessa Therapeutics
Kuur Therapeutics
Royalties None
Spouse disclosures None
Other None

 

Content

Cliona Rooney, Ph.D.

Interest Company
Equity Allovir
Marker
Therapeutics
Scientific Advisory Board

Tessa Therapeutics
Marker Therapeutics
Cell Genix

Research Support Tessa Therapeutics
Royalties Takeda
Marker
Allovir
Bellicum
Spouse Disclosures See Malcolm Brenner
Other None